Retinal Production via Pd-Catalyzed Dehydrogenation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing retinal and its hydrogenated forms suffer from low yields and the use of industrially infeasible oxidants, generating excessive waste, which hinders efficient synthesis of vitamin A and its derivatives.

Innovation Solution

A process involving the selective dehydrogenation of specific compounds in the presence of a transition metal catalyst, preferably Pd(II) catalyst like Pd(OAc)2, using air or O2 as an oxidant, and conducted in a polar aprotic solvent at elevated temperatures, to produce retinal and its hydrogenated forms with improved yield and reduced waste.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional dehydrogenation methods are used to produce retinal, then the synthesis can be performed, but the yield is low and excessive waste is generated

Engineering Contradiction:
Improveyield of retinal productionVSAvoidwaste generation
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The patent changes the chemical parameters of the reaction system by using a Pd-catalyzed dehydrogenation mechanism with molecular oxygen as the oxidant, replacing conventional oxidants. This parameter change achieves both high yield (up to 90%) and minimal waste generation, as the byproduct is only water. The reaction conditions include using Pd(OAc)2 catalyst (0.05-0.5 equiv), molecular sieves (3Å or 4Å) to capture water, and conducting the reaction in solvents like toluene or dichloromethane at room temperature or slightly elevated temperatures.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional oxidants are used in the dehydrogenation process, then the reaction can proceed, but the process is not industrially feasible due to excessive waste

Engineering Contradiction:
Improveindustrial feasibility of retinal productionVSAvoidwaste from oxidant
Core Design Contradiction:
Ease of manufactureVSLoss of substance

Solution Approach 1:

The patent converts the potentially harmful use of stoichiometric oxidants into a beneficial process by using catalytic dehydrogenation with molecular oxygen. The harmful waste generation is transformed into benign water as the only byproduct. The Pd catalyst enables this transformation by facilitating the dehydrogenation reaction where O2 accepts the hydrogen atoms to form water, which is then removed by molecular sieves, making the process environmentally friendly and industrially feasible.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent introduces molecular sieves (3Å or 4Å) as intermediary substances that selectively capture and remove water from the reaction system. These intermediaries facilitate the dehydrogenation process by continuously removing the water byproduct, shifting the equilibrium toward retinal formation and preventing side reactions. The molecular sieves act as a mediator between the dehydrogenation reaction and the final product isolation, enabling high yields and easy purification.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of time

If existing synthesis routes for vitamin A are used, then the production can be maintained, but the process is lengthy and less efficient

Engineering Contradiction:
Improvesynthesis time for vitamin AVSAvoidefficiency of vitamin A synthesis
Core Design Contradiction:
Loss of timeVSProductivity

Solution Approach 1:

The patent performs preliminary dehydrogenation of the dihydroretinal intermediate to generate retinal in high yield and purity before proceeding to the next synthesis steps. By using the Pd-catalyzed dehydrogenation method with molecular sieves to capture water, the reaction reaches high conversion and purity in a single step, eliminating the need for multiple purification steps and intermediate isolations required in conventional routes. This preliminary action with optimized conditions saves significant time in the overall vitamin A synthesis pathway.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process enhances the synthesis of vitamin A and its derivatives by increasing yield and reducing waste, making the production more industrially viable and efficient.

Implementation Method 1

the dehydrogenation is carried out in the presence of at least one transition metal catalyst. Especially in the presence of a Pd catalyst. Especially a Pd(II) catalyst. Very suitable is Pd(OAc)2 as a catalyst.

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

the reaction can be carried out in the presence of air and/or O2 as an oxidant

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS12139452B2Process for the production of retinal
Publication Date: 2024.11.12 DSM IP ASSETS BV
  • US12139452B2 patent drawing
  • US12139452B2 patent drawing
  • US12139452B2 patent drawing

AI summary

The present invention relates to a new process for the production of retinal or hydrogenated form of retinal.